Illumina Faces Order by EU Merger Watchdog to Sell Grail (2)

European Union merger watchdogs are poised to deliver on their threat to order Illumina Inc. to sell cancer-test provider Grail Inc., undoing a $7 billion acquisition it closed without EU permission.

The EU decision could be issued in the coming days, according to a person familiar with the matter who spoke on condition of anonymity. It would be the biggest escalation in a long-running legal fight over the deal, which was vetoed by the European Commission last year over concerns the tie-up would hamper competition.

Illumina intends to appeal any order to sell the company, according to the Financial ...